Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Allahabad HC Grants Relief to Pharma Firm Against Tax Notices

Susmita Roy20 Sept 2025 10:38 PM IST

New Delhi: The Allahabad High Court has quashed orders passed against Safecon Lifescience, holding that proceedings under Section 74 of the GST Act...

Sun Pharmas Dementia Drug Rivastigmine Banned in China

Sun Pharma Told to Limit Phase III Revefenacin Study to Triple Therapy COPD Patients

Susmita Roy20 Sept 2025 7:04 PM IST

New Delhi: Recommending to revise the inclusion criteria so that subjects on triple therapy only shall be included in the study, the Subject Expert...

Box Warning, Dose Limits: India Set To Tighten Nimesulide Use

Susmita Roy19 Sept 2025 5:29 PM IST

New Delhi: The Central Government has instructed pharmaceutical companies to include a prominent "Box Warning" on the widely used painkiller...

CDSCO, ICMR Release Standard Evaluation Protocols for Diagnostic Kits in India

Susmita Roy19 Sept 2025 5:02 PM IST

New Delhi: In a major step towards strengthening diagnostic quality in India, the Indian Council of Medical Research (ICMR) and the Central Drugs...

Jharkhand Health Dept Moves to Derecognise 34 D.Pharm Colleges Over NOC, Infrastructure Lapses

CDSCO Cancels Registration Certificate of G3 Medical Systems for Import of Allergan Cosmetics

Susmita Roy19 Sept 2025 11:00 AM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has confirmed the cancellation of Registration Certificate (RC) No. RC/COS-002850,...

Novartis Loses India Patent on Heart Failure Drug Vymada

Susmita Roy18 Sept 2025 4:00 PM IST

New Delhi: In a major setback for Swiss drugmaker Novartis, the Indian Patent Office (IPO) has cancelled the patent for its heart failure drug Vymada...

One Label, One Rule: Centre Harmonises Legal Metrology Norms with Medical Device Standards

CDSCO Launches Separate Online Provision for Subsequent Importers of Medical Devices, IVDs

Susmita Roy18 Sept 2025 3:00 PM IST

New Delhi: With an aim to streamline the regulatory process for the import of medical devices and in vitro diagnostics (IVDs), the Central Drugs...

India-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and Devices

Cocrystals of Approved APIs to Be Treated as New Drugs, Clarifies CDSCO

Susmita Roy17 Sept 2025 5:22 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a clarification...

Intas Pharma Secures CDSCO Panel Approval for Post-Marketing Study of Tacrolimus Enema

Susmita Roy17 Sept 2025 4:06 PM IST

New Delhi: With the recommendation to include kidney function test (KFT) and blood pressure monitoring in the study volunteers to assess the safety,...

NPPA Continues Price Cap on Orthopedic Knee Replacement Implants for Another Year Till November 15, 2026

NPPA Extends Price Cap on Knee Implants Until November 15, 2025

Susmita Roy16 Sept 2025 8:30 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has...

Wockhardt posts profit of Rs 82 crore in Q2

CDSCO Panel Asks Wockhardt to Revise Phase III Study Protocol for Nafithromycin, Seeks Dosing, Control Arm Changes

Susmita Roy16 Sept 2025 8:01 PM IST

New Delhi: The Subject Expert Committee (SEC), which functions under the Central Drugs Standard Control Organisation (CDSCO), has recommended...

NPPA Fixes Retail Prices of 37 Drug Formulations Including Atorvastatin, Ezetimibe, Telmisartan, Details

NPPA Fixes Retail Prices of 9 Formulations Including Dapagliflozin, Sitagliptin, Aceclofenac FDCs, Details

Susmita Roy16 Sept 2025 2:00 PM IST

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok